Lijia Cui Qian Li Wenmin Guan Wei Yu Xiang Li Weibo Xia Yan Jiang
10.3389/fendo.2022.882144
Front Endocrinol (Lausanne)
2022 Jun 17;13:882144.
angiotensin receptor ii blocker bone mass hypogonadotropic hypogonadism prednisone progressive diaphyseal dysplasia
CC BY
https://pubmed.ncbi.nlm.nih.gov/35784539/
Camurati-Engelmann Syndrome / diagnostic imaging Camurati-Engelmann Syndrome / drug therapy Camurati-Engelmann Syndrome / genetics
Camurati-Engelmann Syndrome / diagnostic imaging Camurati-Engelmann Syndrome / drug therapy Camurati-Engelmann Syndrome / genetics Case Reports Review Research Support, Non-U.S. Gov't Adolescent Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Bone Density Female Glucocorticoids / therapeutic use Humans Losartan / therapeutic use Pain Puberty Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Glucocorticoids Losartan
PMC9247158
35784539
Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature
2022